PET/CT Molecular Imaging Unit, National Institute of Neurology and Neurosurgery, Mexico City, Mexico.
PET/CT Molecular Imaging Unit, National Institute of Neurology and Neurosurgery, Mexico City, Mexico.
Psychosomatics. 2020 Jan-Feb;61(1):39-48. doi: 10.1016/j.psym.2019.08.007. Epub 2019 Sep 5.
Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis causes substantial neurological disability. Autoantibodies causing encephalitis directed against the neuronal cell surface or synapse are of diagnostic importance giving the possibility of successful immunotherapy.
In this study, we aim to provide supporting evidence that brain 18F-FDG-PET may be helpful in identifying likely patterns of regional brain glucose metabolism.
Thirty-three patients (18 men and 15 women; age range of 17-55 y) with positive NMDA receptor antibody encephalitis that underwent an 18F-FDG-PET imaging examination were prospectively selected and compared with a reference group of 14 brain 18F-FDG-PET scans from healthy volunteers using voxel-based statistical analysis. Clusters of hyper- and hypo-metabolism were reported for the whole sample of patients (FWE-corrected P < 0.05), and uncorrected at P < 0.005 for a group of relapsed patients.
Mixed metabolic patterns (focal/bilateral hypermetabolism in the temporal lobe, insula, and cerebellum; associated with severe bilateral hypometabolism in the occipital and parietal lobes) were found.
Our findings suggest that 18F-FDG-PET should be included as an imaging tool when assessing affected patients in the clinical workup to rule out anti-NMDA encephalitis and help determine the most effective treatment.
抗 N-甲基-D-天冬氨酸(NMDA)受体脑炎会导致严重的神经功能障碍。针对神经元细胞表面或突触的脑炎自身抗体具有诊断意义,为免疫治疗提供了可能。
本研究旨在提供支持证据,表明脑 18F-FDG-PET 可能有助于识别可能的区域性脑葡萄糖代谢模式。
前瞻性选择了 33 例 NMDA 受体抗体脑炎阳性患者(18 名男性,15 名女性;年龄 17-55 岁)进行 18F-FDG-PET 成像检查,并与 14 名健康志愿者的脑 18F-FDG-PET 扫描参考组进行比较,使用基于体素的统计分析。报告了整个患者样本的代谢亢进和代谢减退的簇(FWE 校正 P < 0.05),并对复发患者组进行了未校正的 P < 0.005。
发现了混合代谢模式(颞叶、岛叶和小脑局灶性/双侧代谢亢进;与枕叶和顶叶严重双侧代谢减退相关)。
我们的研究结果表明,在临床评估中,应将 18F-FDG-PET 作为评估受影响患者的影像学工具之一,以排除抗 NMDA 脑炎,并帮助确定最有效的治疗方法。